February 2015


CenterState CEO seeds Ichor macular degeneration program with Grants for Growth

LaFayette, NY: Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, has received a $25,000 grant from CenterState CEO through its Grants for Growth program. Announced in CenterState CEO’s February 2015 Newsletter, this funding will be used to develop an enzyme augmentation therapy to treat age-related macular degeneration, the leading cause of blindness and vision

Read more